XML 58 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities    
Net income $ 59,636 $ 70,261
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 9,793 8,803
Stock-based compensation expense 11,391 10,135
Loss on debt extinguishment 10,832  
Deferred income taxes (514) (804)
Distributions from unconsolidated subsidiaries   7,432
Equity in income of unconsolidated subsidiaries   (14,849)
(Gain) loss on disposition of assets 846 1,399
Changes in assets and liabilities:    
Cash held in escrow (6,018) 6,077
Accounts receivable (4,465) (13,324)
Inventories (215,771) (243,355)
Prepaid expenses and other assets 33,346 (32,640)
Accounts payable (11,212) 3,267
Accrued expenses and other liabilities (53,901) (9,285)
Mortgage loans held for sale 17,073 (10,114)
Net cash provided by (used in) operating activities (148,964) (216,997)
Investing activities    
Purchases of property and equipment (11,633) (11,893)
Business combinations, net of acquired cash   (28,036)
Other investing activities 78 272
Net cash provided by (used in) investing activities (11,555) (39,657)
Financing activities    
Borrowings under revolving credit facilities 1,184,800 520,000
Payments on revolving credit facilities (1,108,500) (284,000)
Proceeds from issuance of senior notes due 2027 500,000  
Extinguishment of senior notes due 2022 (391,942)  
Proceeds from issuance of insurance premium notes and other 12,629 11,838
Principal payments on insurance notes payable and other (19,275) (2,173)
Extinguishments of debt assumed in business combination   (94,231)
Debt issuance costs (6,075) (3,521)
Net payments on mortgage repurchase facilities (26,757) 9,008
Net proceeds from issuances of common stock 25,817 31,230
Repurchases of common stock upon vesting of stock based compensation (3,588) (5,483)
Repurchases of common stock under our stock repurchase program (1,439)  
Net cash provided by (used in) financing activities 165,670 182,668
Net increase (decrease) 5,151 (73,986)
Cash and cash equivalents and Restricted cash, Beginning of period 36,441 93,713
Cash and cash equivalents and Restricted cash, End of period 41,592 19,727
Supplemental cash flow disclosure    
Cash paid for income taxes 20,722 39,326
Cash and cash equivalents and Restricted cash    
Cash and cash equivalents 38,508 15,927
Restricted cash (Note 6) $ 3,084 $ 3,800